These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28912936)
1. Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial. Alavi S; Abolhasani E; Asadi S; Nilforoushzadeh M J Lasers Med Sci; 2017; 8(1):1-6. PubMed ID: 28912936 [No Abstract] [Full Text] [Related]
2. A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin. Dev T; Sreenivas V; Sharma VK; Sahni K; Bhari N; Sethuraman G Int J Dermatol; 2020 Dec; 59(12):1525-1530. PubMed ID: 33017045 [TBL] [Abstract][Full Text] [Related]
3. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study. Zhou Y; Li Y; Hamblin MR; Wen X Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099 [TBL] [Abstract][Full Text] [Related]
5. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma. Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Yue B; Yang Q; Xu J; Lu Z Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275 [TBL] [Abstract][Full Text] [Related]
7. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. Laothaworn V; Juntongjin P J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121 [No Abstract] [Full Text] [Related]
8. A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy alone and in combination with erbium:YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis. Nilforoushzadeh MA; Zolghadr S; Heidari-Kharaji M; Alavi S; Mahmoudbeyk M Lasers Med Sci; 2020 Jul; 35(5):1171-1177. PubMed ID: 31916020 [TBL] [Abstract][Full Text] [Related]
9. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. Ustuner P; Balevi A; Ozdemir M J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378 [TBL] [Abstract][Full Text] [Related]
10. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Kar HK; Gupta L; Chauhan A Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. Lee DB; Suh HS; Choi YS J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244 [TBL] [Abstract][Full Text] [Related]
12. Combining Low Power Fractional CO Esmat S; Z Elramly A; Shahin D; Hilal RF Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829 [TBL] [Abstract][Full Text] [Related]
13. The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study. Kaminaka C; Furukawa F; Yamamoto Y Dermatol Surg; 2017 Sep; 43(9):1120-1133. PubMed ID: 28328709 [TBL] [Abstract][Full Text] [Related]
14. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527 [TBL] [Abstract][Full Text] [Related]
15. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma. Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814 [TBL] [Abstract][Full Text] [Related]
16. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V. Lueangarun S; Namboonlue C; Tempark T J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. Lee DB; Suh HS; Choi YS J Cosmet Laser Ther; 2014 Dec; 16(6):264-70. PubMed ID: 24245978 [TBL] [Abstract][Full Text] [Related]
18. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study. Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study. Al-Dhalimi MA; Yasser RH J Cosmet Laser Ther; 2021 May; 23(3-4):65-71. PubMed ID: 34407729 [TBL] [Abstract][Full Text] [Related]
20. A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients. Bansal C; Naik H; Kar HK; Chauhan A J Cutan Aesthet Surg; 2012 Oct; 5(4):266-72. PubMed ID: 23378709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]